Anti-psgl-1 antibodies and methods of identification and use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2724415

The present invention is directed to antibodies and binding fragments thereof, which bind with high affinity and specificity to human P-selectin glycoprotein ligand 1 (PSGL-1) and which block both selectin and chemokine binding to PSGL-1 expressed on leukocytes, lymphocytes and endothelial cells and thus which inhibit migration and/or rolling of these cells and to methods for screening for such antibodies and binding fragments thereof and to methods of therapeutic use thereof.

L'invention concerne des anticorps et des fragments de liaison de ces derniers, qui se lient avec une affinité et une spécificité élevées à la glycoprotéine ligand de la sélectine P humaine 1 (PSGL-1) et qui bloquent la liaison de la sélectine et de la chimiokine à la PSGL-1 exprimée sur les leucocytes, les lymphocytes et les cellules endothéliales, inhibant par conséquent la migration et/ou le roulement desdites cellules. L'invention porte aussi sur des procédés de criblage desdits anticorps et fragments de ces derniers et sur des procédés d'utilisation thérapeutique de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-psgl-1 antibodies and methods of identification and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-psgl-1 antibodies and methods of identification and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-psgl-1 antibodies and methods of identification and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1685773

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.